August F&O series to begin on buoyant note
August F&O series to begin on buoyant note

August F&O series to begin on buoyant note

DSIJ Intelligence-3 Article rating: 4.5

Despite markets losing close to a per cent on the Futures & Options (F&O) expiry day, the July series ended with gains of almost 868 points or 8.47 per cent. Early trends in SGX Nifty suggests that the first trading session of the August F&O series is likely to begin with optimism. At 7:45 AM, SGX Nifty is trading with gains of 0.57 per cent at 11,147.50 level.

Vaillant Group partners with TCS
Vaillant Group partners with TCS

Vaillant Group partners with TCS

DSIJ Intelligence Article rating: 3.4

Tata Consultancy Services (TCS) has expanded partnership with Vaillant Group, a global leader in heating, ventilation and air-conditioning technology, to streamline the latter’s business processes and implement those on a single, digital enterprise process platform to support its business model transformation and future growth.

Sensex, Nifty down by nearly one per cent; LT Foods (Daawat) soars by nearly 16 per cent, Hathway tanks by five per cent
Sensex, Nifty down by nearly one per cent; LT Foods (Daawat) soars by nearly 16 per cent, Hathway tanks by five per cent

Sensex, Nifty down by nearly one per cent; LT Foods (Daawat) soars by nearly 16 per cent, Hathway tanks by five per cent

DSIJ Intelligence Article rating: 4.2

Selling continued to be witnessed in domestic markets as Sensex declined by 335.06 points or 0.88 per cent to settle at 37,736.07 while Nifty fell by 100.70 points or 0.90 per cent to close at 11,102.15.

RPP Infra: Stock price gives away rally despite new order
RPP Infra: Stock price gives away rally despite new order

RPP Infra: Stock price gives away rally despite new order

Pratik Shastri Article rating: 3.3

It also mentioned that with this new order, its order book would be well-placed and might reach Rs 2,000 crore in FY21. As of the end of FY20, the order book stood at Rs 1,788.2 crore.

Lincoln Pharma launches Vitamin C+ Zinc tablets; stock gains two per cent
Lincoln Pharma launches Vitamin C+ Zinc tablets; stock gains two per cent

Lincoln Pharma launches Vitamin C+ Zinc tablets; stock gains two per cent

DSIJ Intelligence Article rating: 3.8

Healthcare company Lincoln Pharmaceuticals announced the launch of its Vitamin C+ Zinc tablets in Indian markets thus, consolidating its position in a market estimated at about Rs 150 crore in the country and growing at 15 per cent per annum.

RSS
First28302831283228332835283728382839Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR